Qube Research & Technologies (QRT)’s Monte Rosa Therapeutics GLUE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GLUE Stock Details GLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-147,726	Closed	-$1.09M	–	3818
2025 Q3	$1.09M	Sell	147,726 -55,694	-27%	-$295K	﹤0.01%	2472
2025 Q2	$917K	Buy	203,420 +154,722	+318%	+$690K	﹤0.01%	2496
2025 Q1	$226K	Sell	48,698 -37,847	-44%	-$232K	﹤0.01%	2832
2024 Q4	$601K	Buy	+86,545	New	+$649K	﹤0.01%	2386
2024 Q3	–	Sell	-16,566	Closed	-$62K	–	3613
2024 Q2	$62K	Buy	+16,566	New	+$84.5K	﹤0.01%	2699
2021 Q3	–	Sell	-13,100	Closed	-$297K	–	2412
2021 Q2	$297K	Buy	+13,100	New	+$267K	﹤0.01%	1588

Other funds holding GLUE

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GLUE Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Monte Rosa Therapeutics (GLUE) in Q4 2025, closing a stake of 147,726 shares — an estimated $1.09M sold.

Qube Research & Technologies (QRT) first reported a position in GLUE in Q2 2021 and held it in 6 quarters. The position peaked at $1.09M in Q3 2025. 161 funds tracked by Wall St. Rank hold GLUE as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining Monte Rosa Therapeutics position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 147,726 Monte Rosa Therapeutics shares in Q4 2025, an estimated $1.09M.
Qube Research & Technologies (QRT) first reported a position in Monte Rosa Therapeutics in Q2 2021 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Monte Rosa Therapeutics position peaked at $1.09M in Q3 2025.
161 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.